COMP <GO>
THO vs TMO // OPERATING MARGIN
Thor Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: THO 4
— TMO 9
▲ OPERATING MARGIN LEADER: TMO
LAST: $73.62 (+3.60%) • MKT CAP: $3.80B
operating-margins
3.30%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (THO VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | THO | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.00% | 9.30% | -4.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.5x | 30.4x | -23.90 | THO | /valuation <GO> |
| Free Cash Flow Yield | 3.86% | 2.40% | +1.46 | THO | /fcf-yield <GO> |
| Operating Margin ACTIVE | 3.30% | 17.40% | -14.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.70% | 15.10% | -12.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -4.60% | 3.90% | -8.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.27 | 4.50 | -1.23 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.2 | 62.9 | -1.70 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.94 | +0.01 | THO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.7x | 36.3x | -22.60 | THO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.80B | $262.22B | -$258.42B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | THO REV | TMO REV | THO GROSS % | TMO GROSS % | THO FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.58B | $44.56B | 14.0% | — | $146.8M | $6.29B |
| FY 2024 | $10.04B | $42.88B | 14.5% | — | $93.6M | $7.27B |
| FY 2023 | $11.12B | $42.86B | — | — | $481.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
THO // BETA 0.95
TMO // BETA 0.94